Allegheny Financial Group »

Taysha Gene Therapies shares owned by Allegheny Financial Group

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Allegheny Financial Group from 13F filings

Historical chart of Allegheny Financial Group investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Allegheny Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Allegheny Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $145k 26k 5.50
2025-09-30 $49k 15k 3.27

More positions owned by Allegheny Financial Group

Putnam Etf Trust Focused Lar Cap (PVAL)
J P Morgan Exchange Traded F Flexible Debt Et (JFLX)
Ea Series Trust City Diffnt Invt (CDIG)
Diamond Hill Funds Large Cap Concen (DHLX)
Ishares Tr Core Div Grwth (DGRO)
NVR (NVR)
Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Erie Indty Cl A (ERIE)
Exxon Mobil Corporation (XOM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr MRGSTR MD CP GRW (IMCG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Mfs Active Exchange Traded F Growth Etf (MFSG)
Microsoft Corporation (MSFT)

View all positions for Allegheny Financial Group

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies